BofA/Merrill Lynch added Novo Nordisk A/S (NVO) to its Europe 1 List
Tweet
Share
E-mailGet Alerts NVO Hot Sheet
Price: $48.66 +3.71%
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
BofA/Merrill Lynch added Novo Nordisk A/S (NYSE: NVO) to its Europe 1 List.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PepsiCo Scraps Coverage of Weight-Loss Drugs for Employees - Bloomberg
- Tractor Supply issues $500M in senior notes due 2032
- Dollar Tree (DLTR) PT Raised to $138 at Truist Securities
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
